5.2 Patient Counselling & Medicines Safety

5.2 Patient Counselling & Medicines Safety

Patient counselling is not merely an operational courtesy in Irish community pharmacy; it is a fundamental statutory duty mandated by the Pharmaceutical Society of Ireland (PSI) Code of Conduct and Core Standards. Effective patient communication bridges the gap between clinical prescribing and real-world medicine administration. Pharmacists are uniquely positioned as the most accessible healthcare professionals in Ireland to ensure patients understand their therapy, adhere to treatment regimens, recognize potential adverse effects, and safely manage high-risk medications.

---

Structured Counselling Frameworks (WWHAM & ASMETHOD)

To perform consistent, comprehensive patient assessments and deliver structured counselling in a busy community pharmacy environment, pharmacists utilize validated consultation frameworks.

The WWHAM Framework

The WWHAM acronym is widely deployed in Irish primary care for evaluating patient requests for over-the-counter (OTC) medicines and initial prescription presentations:

• W — Who is the medicine for? (Patient age, gender, pregnancy/lactation status, relationship to the person presenting).
• W — What are the symptoms? (Exact nature, severity, location, and character of the complaint).
• H — How long have the symptoms been present? (Onset, duration, pattern of progression).
• A — Action already taken? (Previous self-treatment, OTC products tried, non-pharmacological interventions).
• M — Medication currently being taken? (Prescription drugs, OTC medicines, herbal supplements, known drug allergies).

The ASMETHOD Framework

For more complex OTC consultations and differential diagnosis, the ASMETHOD framework provides deeper systematic inquiry:

• A — Age / Appearance: Visual assessment of distress, age-appropriate dosing considerations.
• S — Symptoms: Primary and secondary clinical manifestations.
• M — Medication: Full review of current prescribed and non-prescribed therapy.
• E — Extra symptoms: Associated systemic red flags (e.g., fever, weight loss, shortness of breath).
• T — Time / Duration: Timeline of symptom onset and persistence.
• H — History: Past medical history and underlying chronic conditions.
• O — Other people: Are family members or close contacts experiencing identical symptoms?
• D — Danger signs: Immediate referral triggers requiring urgent GP or Emergency Department direction.

---

High-Risk Medicines Management Protocols

Certain therapeutic classes possess narrow therapeutic indices or complex posology, carrying a significant risk of severe toxicity or adverse outcomes if mismanaged. In Irish community practice, specific safety protocols and clinical verification checks are mandatory for these high-alert medications.

---

Concordance vs. Compliance in Pharmacy Practice

Modern clinical practice in Ireland distinguishes sharply between historical concepts of patient compliance and contemporary principles of concordance.

• Compliance (Adherence): Refers to the extent to which a patient passively follows the prescriber's explicit instructions. It represents a one-way directive from clinician to patient.
• Concordance: Defines a therapeutic alliance and shared decision-making process between the patient and healthcare provider. Concordance respects the patient's personal beliefs, concerns, and lifestyle, establishing an agreed treatment plan.

Addressing Non-Adherence in Community Pharmacy

Pharmacists evaluate two primary forms of non-adherence during routine consultations:

1. Intentional Non-Adherence: The patient actively decides not to take a medication due to fear of side effects, denial of disease, personal health beliefs, or perceived lack of efficacy. Intervention: Empathic exploratory questioning, educational counselling, addressing misconceptions, and reviewing alternative formulations with the prescriber.
2. Unintentional Non-Adherence: The patient intends to take the medicine but is prevented by practical barriers such as forgetfulness, complex multi-dose schedules, cognitive decline, physical dexterity issues, or difficulty opening packaging. Intervention: Simplification of dosing regimens, provision of Monitored Dosage Systems (MDS / blister packaging), large-print labels, or reminder alarms.

---

Adverse Drug Reaction (ADR) Reporting & HPRA Pharmacovigilance

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. In Ireland, the Health Products Regulatory Authority (HPRA) is the statutory body responsible for monitoring drug safety.

+-----------------------------------------------------------------------------------+
|                    HPRA PHARMACOVIGILANCE & ADR REPORTING FLOW                    |
+-----------------------------------------------------------------------------------+
| 1. PATIENT REPORTS ADVERSE EFFECT OR PHARMACIST IDENTIFIES ADR DURING CONSULTATION|
+-----------------------------------------------------------------------------------+
                                          |
                                          v
+-----------------------------------------------------------------------------------+
| 2. ASSESS ADR SEVERITY & NOVELTY                                                  |
|    Is it a serious reaction? Is it a Black Triangle (▼) intensive monitoring drug? |
+-----------------------------------------------------------------------------------+
                                          |
                                          v
+-----------------------------------------------------------------------------------+
| 3. CLINICAL MANAGEMENT                                                            |
|    Provide immediate patient advice; liaise with GP for treatment adjustment      |
+-----------------------------------------------------------------------------------+
                                          |
                                          v
+-----------------------------------------------------------------------------------+
| 4. SUBMIT YELLOW CARD / ONLINE ADR REPORT TO HPRA                                 |
|    Submit details via www.hpra.ie (Product, Patient initials, ADR, Reporter ID)  |
+-----------------------------------------------------------------------------------+
                                          |
                                          v
+-----------------------------------------------------------------------------------+
| 5. HPRA SIGNAL DETECTION & EUDRAVIGILANCE DATABASE INTEGRATION                    |
|    HPRA evaluates signal; may issue Safety Alerts, SmPC updates, or Drug Recalls   |
+-----------------------------------------------------------------------------------+

The Black Triangle Symbol (▼)

Medicinal products subject to additional monitoring by European regulatory authorities display an inverted black triangle symbol (▼) in their Summary of Product Characteristics (SmPC) and Package Leaflet. This includes all new active substances, biological products, and medicines approved under conditional or exceptional circumstances. Pharmacists are under a heightened professional obligation to report any suspected adverse reaction observed with Black Triangle medicines, regardless of severity.